Quantum State Preparation & Representation
212 papers from Europe PMC
Quantum State Preparation & Representation Research Context
This Quantum Articles category organizes published quantum research papers so readers can browse focused work by topic, source, and year.
Showing 49-60 of 212
From Classical to Quantum: Extending Prometheus to Uncover Quantum Critical Behavior in Disordered Transverse Field Ising Chains
Yee B, Collins W, Rutkowski M.
2025
Europe PMC
Europe PMC
Geometry and quantum brachistochrone analysis of multiple entangled spin-1/2 particles under all-range Ising interaction.
Amghar B, Yachi M, Amghar M, Almousa M, El-Latif AAA, Slaoui A.
2025
Europe PMC
Sci Rep
Instanton-like effect caused by qubit-boson interaction in light of quantum simulation.
Hirokawa M.
2025
Europe PMC
Sci Rep
IRIS-QResNet: A Quantum-Inspired Deep Model for Efficient Iris Biometric Identification and Authentication.
Dahan NA, Jaha ES.
2025
Europe PMC
Sensors (Basel)
Mesoscopic Quantum Effect: The Interaction of Electron Phenomena at the Mesoscopic Scale.
Chen K, Liu L.
2025
Europe PMC
Nanomaterials (Basel)
Multi-Party Semi-Quantum Simultaneous Ascending Auction Protocol Based on Single-Particle States.
Wu X, Yang Y, Wang B, Zhang Y, Han Y.
2025
Europe PMC
Entropy (Basel)
Nested Grover's Algorithm for Tree Search.
Wichert A.
2025
Europe PMC
Entropy (Basel)
Nonclassical features of an open qubit cavity QED system.
Manan A, Rahman AU, Arian Zad H, Ali H, Ali A, Al-Kuwari S, Haddadi S.
2025
Europe PMC
Sci Rep
On the First Quantum Correction to the Second Virial Coefficient of a Generalized Lennard-Jones Fluid.
Parejo D, Santos A.
2025
Europe PMC
Entropy (Basel)
On-chip quantum states generation by incoherent light.
Song YW, Zhao H, Chen L, Li YH, Li EZ, Gao MY, Chen RH, Han ZQ, Xie MY, Guo GC, Zhou ZY, Shi BS.
2025
Europe PMC
Nat Commun
OP41 Using Horizon Scanning To Identify Emerging Quantum Technologies In Health Care
Unknown
2025
Europe PMC
Int J Technol Assess Health Care
OP42 Cost-Utility Analysis Of Axicabtagene Ciloleucel (Yescarta) Versus Standard Care For Relapsed Or Refractory Large B-Cell Lymphoma – Health Payer Perspective
Unknown
2025
Europe PMC
Int J Technol Assess Health Care